与177Lu-DOTATATE和恶性伞骨瘤的卡佩西塔宾疗法合并
The role of concomitant peptide receptor radionuclide therapy (PRRT) and capecitabine therapy has shown benefit in gastroenteropancreatic neuroendocrine tumors. However, data reporting its role in…
The role of concomitant peptide receptor radionuclide therapy (PRRT) and capecitabine therapy has shown benefit in gastroenteropancreatic neuroendocrine tumors. However, data reporting its role in…
问问我们的产品、服务或公司 我从这个网站上回答.
答复来自该网站,可能不完整。 对话被储存起来,这样我们就可以改进它们.
